Lineage Cell Therapeutics
LCTX
#8657
Rank
ยฃ90 M
Marketcap
ยฃ0.48
Share price
-6.45%
Change (1 day)
-37.72%
Change (1 year)

EPS for Lineage Cell Therapeutics (LCTX)

EPS in 2023 (TTM): -ยฃ0.11

According to Lineage Cell Therapeutics 's latest financial reports the company's current EPS (TTM) is -ยฃ0.10. In 2022 the company made an earnings per share (EPS) of -ยฃ0.12 an increase over its 2021 EPS that were of -ยฃ0.21.

EPS history for Lineage Cell Therapeutics from 1996 to 2023

Annual EPS

Year EPS Change
2023 (TTM)-ยฃ0.11-8.85%
2022-ยฃ0.12-42.31%
2021-ยฃ0.2185.71%
2020-ยฃ0.11250%
2019-ยฃ0.03177-88.57%
2018-ยฃ0.28105.88%
2017-ยฃ0.14-153.13%
2016ยฃ0.25-154.24%
2015-ยฃ0.475.36%
2014-ยฃ0.44-30.86%
2013-ยฃ0.6488.37%
2012-ยฃ0.3419.44%
2011-ยฃ0.2933.33%
2010-ยฃ0.2168.75%
2009-ยฃ0.13-5.88%
2008-ยฃ0.14183.33%
2007-ยฃ0.04766-25%
2006-ยฃ0.06355-27.27%
2005-ยฃ0.08738-38.89%
2004-ยฃ0.1438.46%
2003-ยฃ0.10-43.48%
2002-ยฃ0.18-26.63%
2001-ยฃ0.25-28.75%
2000-ยฃ0.35-13.73%
1999-ยฃ0.41
1997-ยฃ0.263.13%
1996-ยฃ0.25

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
-ยฃ1.73 1,576.92%๐Ÿ‡บ๐Ÿ‡ธ USA